S'abonner

Bayesian Analysis of the Pragmatic Airway Resuscitation Trial - 25/11/19

Doi : 10.1016/j.annemergmed.2019.05.009 
Henry E. Wang, MD, MS a, , Andrew Humbert, MS c, Graham Nichol, MD d, Jestin N. Carlson, MD, MS e, f, Mohamud R. Daya, MD, MS g, Ryan P. Radecki, MD h, Matthew Hansen, MD, MCR g, Clifton W. Callaway, MD, PhD e, Claudia Pedroza, PhD b
a Department of Emergency Medicine, The University of Texas Health Science Center at Houston, Houston, TX 
b Department of Pediatrics, The University of Texas Health Science Center at Houston, Houston, TX 
c Clinical Trials Center, Department of Biostatistics, University of Washington, Seattle, WA 
d Departments of Emergency Medicine and Medicine, University of Washington, Seattle, WA 
e University of Pittsburgh, Pittsburgh, PA 
f Department of Emergency Medicine, Saint Vincent Hospital, Allegheny Health Network, Erie, PA 
g Department of Emergency Medicine, Oregon Health & Science University, Portland, OR 
h Department of Emergency Medicine, Northwest Permanente, Portland, OR 

Corresponding Author.

Abstract

Study objective

Intubation and laryngeal tube insertion are common airway management strategies in out-of-hospital cardiac arrest. Bayesian analysis offers an alternate statistical approach to assess the results of a trial. We use Bayesian analysis to compare the effectiveness of initial laryngeal tube versus initial intubation strategies on outcomes after out-of-hospital cardiac arrest in the Pragmatic Airway Resuscitation Trial.

Methods

We performed a post hoc Bayesian analysis of the Pragmatic Airway Resuscitation Trial. We defined prior distributions representing neutral or skeptical estimates of laryngeal tube benefit. Using Bayesian log binomial models, we fit models for 72-hour survival, hospital survival, and hospital survival with favorable neurologic status. We estimated the posterior probability (the probability of observing an effect difference between treatment groups) of the benefit of laryngeal tube over intubation on out-of-hospital cardiac arrest outcomes.

Results

The parent trial enrolled 3,004 patients (1,505 laryngeal tube, 1,499 intubation). Under a neutral prior distribution (relative risk 1.0), laryngeal tube was better than intubation (72-hour survival risk difference 1.8% [95% credible interval {CrI} –0.9% to 4.5%], posterior probability 91%; hospital survival 1.4% [95% CrI –0.4% to 3.4%], posterior probability 93%; and hospital survival with favorable neurologic status 0.7% [95% CrI –0.5% to 2.1%], posterior probability 86%). Under a skeptical prior distribution (relative risk 0.83 to 0.92), laryngeal tube was also better than intubation (72-hour survival risk difference 1.7% [95% CrI –0.9% to 4.3%], posterior probability 89%; hospital survival 1.3% [95% CrI –0.5% to 3.3%], posterior probability 91%; and hospital survival with favorable neurologic status 0.6% [95% CrI –0.5% to 2.0%], posterior probability 82%).

Conclusion

Under various prior assumptions, post hoc Bayesian analysis of the Pragmatic Airway Resuscitation Trial confirmed better out-of-hospital cardiac arrest outcomes with a strategy of initial laryngeal tube than initial intubation.

Le texte complet de cet article est disponible en PDF.

Plan


 Please see page 810 for the Editor’s Capsule Summary of this article.
 Supervising editor: Steven M. Green, MD. Specific detailed information about possible conflict of interest for individual editors is available at editors. Dr. Green was the supervising editor on this article. Dr. Wang did not participate in the editorial review or decision to publish this article.
 Author contributions: HEW and CP were responsible for design and conceptualization of the study. HEW and GN obtained funding. All authors were responsible for execution of the study, data collection, and critical review and approval of the article. AH and CP were responsible for data analysis. HEW, AH, and CP were responsible for composition of the article. HEW takes responsibility for the paper as a whole.
 All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). Supported by award UH2/UH3-HL125163 from the National Heart, Lung, and Blood Institute (NHLBI). The Resuscitation Outcomes Consortium institutions participating in the trial were supported by a series of cooperative agreements from the NHLBI, including 5U01 HL077863 (University of Washington Data Coordinating Center), HL077866 (Medical College of Wisconsin), HL077871 (University of Pittsburgh), HL077873 (Oregon Health & Science University), HL077881 (University of Alabama at Birmingham), and HL077887 (University of Texas Southwestern Medical Center/Dallas). Ambu, Inc. provided laryngeal tube airways to replace equipment used by EMS agencies during the trial. Dr. Nichol receives salary support from the University of Washington through the Leonard A. Cobb Medic One Foundation Endowed Chair in Prehospital Emergency Care. The Medic One Foundation raises funds to promote improvements in out-of-hospital emergency care. He receives support from ZOLL Medical Corp, which manufactures portable ventilators. He is a consultant to GE Healthcare, which manufactures portable ventilators. His activities with ZOLL Medical and GE Healthcare are unrelated to ventilators. He is a consultant to ZOLL Circulation Inc, a subsidiary of ZOLL Medical Corp. He has been assigned a provisional patent for a combination product to modify reperfusion injury to the University of Washington. Dr. Carlson receives support from the American Heart Association for intubation research.
 Trial registration number: NCT02419573
 The NHLBI had the following roles in the study: design and conduct of the study; review, advising, and approval of study design; participation in monitoring enrollment progress; and assembly of the data and safety and monitoring board. Ambu, Inc. did have not any role in the design, execution, or analysis of the trial. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHLBI or the National Institutes of Health.
 Readers: click on the link to go directly to a survey in which you can provide 2XSJWZS to Annals on this particular article.
 A podcast for this article is available at www.annemergmed.com.
 Continuing Medical Education exam for this article is available at ACEPeCME/.


© 2019  American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 74 - N° 6

P. 809-817 - décembre 2019 Retour au numéro
Article précédent Article précédent
  • Epinephrine in Out-of-Hospital Cardiac Arrest: What Is the Role of the Timing Interval?
  • Nicholas M. Mohr, Brett Faine
| Article suivant Article suivant
  • Male With Anterior Left Knee Pain
  • Sarah B. Dubbs, Adam C. Richardson, Kelly M. Blosser, Semhar Z. Tewelde

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.